Eduardo Moros

Prof. Dr. Eduardo Moros

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2017 in Medical Physics
Verified
Journal Article
Closed access
PDF file
MSMuhammad Shafiq‐Ul‐Hassan
Muhammad Shafiq‐Ul‐Hassan
GZGeoffrey G. Zhang
Geoffrey G. Zhang
KLKujtim Latifi
Kujtim Latifi
GUGhanim Ullah
Ghanim Ullah
DHDylan C. Hunt
Dylan C. Hunt
EMEduardo Moros
Eduardo Moros

1 February 2017 in The Lancet Oncology
Verified
Journal Article
Closed access
JSJacob G Scott
Jacob G Scott
ABAnders Berglund
Anders Berglund
MSMichael J Schell
Michael J Schell
IMIvaylo Mihaylov
Ivaylo Mihaylov
WFWilliam J Fulp
William J Fulp
JTJavier F Torres-Roca
Javier F Torres-Roca

19 June 2019 in Physical Biology
Verified
Journal Article
Open access
PDF file
RRRussell Rockne
Russell Rockne
AHAndrea Hawkins-Daarud
Andrea Hawkins-Daarud
KSKristin R Swanson
Kristin R Swanson
JSJames P Sluka
James P Sluka
JGJames A Glazier
James A Glazier
JSJacob G Scott
Jacob G Scott
Whether the nom de guerre is Mathematical Oncology, Computational or Systems Biology, Theoretical Biology, Evolutionary Oncology, Bioinformatics, or simply Basic Science, there is no denying that mathematics continues to play an increasingly prominent role in cancer research. Mathematical Oncology—defined here simply as the use of mathematics in cancer research—complements and overlaps with a number of other fields that rely on mathematics as a core methodology. As a result, Mathematical Oncology has a broad scope, ranging from theoretical studies to clinical trials designed with mathematical models. This Roadmap differentiates Mathematical Oncology from related fields and demonstrates specific areas of focus within this unique field of research. The dominant theme of this Roadmap is the personalization of medicine through mathematics, modelling, and simulation. This is achieved through the use of patient-specific clinical data to: develop individualized screening strategies to detect cancer earlier; make predictions of response to therapy; design adaptive, patient-specific treatment plans to overcome therapy resistance; and establish domain-specific standards to share model predictions and to make models and simulations reproducible. The cover art for this Roadmap was chosen as an apt metaphor for the beautiful, strange, and evolving relationship between mathematics and cancer.

1 May 2017 in The Lancet Oncology
Verified
Journal Article
Closed access
JCJimmy J Caudell
Jimmy J Caudell
JTJavier F Torres-Roca
Javier F Torres-Roca
RGRobert J Gillies
Robert J Gillies
HEHeiko Enderling
Heiko Enderling
SKSungjune Kim
Sungjune Kim
LHLouis B Harrison
Louis B Harrison

12 July 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSMuhammad Shafiq-Ul-Hassan
Muhammad Shafiq-Ul-Hassan
KLKujtim Latifi
Kujtim Latifi
GZGeoffrey G Zhang
Geoffrey G Zhang
Ghanim UllahGhanim Ullah
Ghanim Ullah
RGRobert Gillies
Robert Gillies
EMEduardo Moros
Eduardo Moros
Radiomic features are potential imaging biomarkers for therapy response assessment in oncology. However, the robustness of features with respect to imaging parameters is not well established. Previously identified potential imaging biomarkers were found to be intrinsically dependent on voxel size and number of gray levels (GLs) in a recent texture phantom investigation. Here, we validate the voxel size and GL in-phantom normalizations in lung tumors. Eighteen patients with non-small cell lung cancer of varying tumor volumes were analyzed. To compare with patient data, phantom scans were acquired on eight different scanners. Twenty four previously identified features were extracted from lung tumors. The Spearman rank (rs) and interclass correlation coefficient (ICC) were used as metrics. Eight out of 10 features showed high (rs > 0.9) and low (rs < 0.5) correlations with number of voxels before and after normalizations, respectively. Likewise, texture features were unstable (ICC < 0.6) and highly stable (ICC > 0.8) before and after GL normalizations, respectively. We conclude that voxel size and GL normalizations derived from a texture phantom study also apply to lung tumors. This study highlights the importance and utility of investigating the robustness of radiomic features with respect to CT imaging parameters in radiomic phantoms.

1 September 2005 in International Journal of Hyperthermia
Verified
Journal Article
Closed access
RAR. M. Arthur
R. M. Arthur
WSW. L. Straube
W. L. Straube
JTJ. W. Trobaugh
J. W. Trobaugh
EMEduardo Moros
Eduardo Moros
Ultrasound is an attractive modality for temperature monitoring because it is non-ionizing, convenient, inexpensive and has relatively simple signal processing requirements. This modality may be useful for temperature estimation if a temperature-dependent ultrasonic parameter can be identified, measured and calibrated. The most prominent methods for using ultrasound as a non-invasive thermometer exploit either (1) echo shifts due to changes in tissue thermal expansion and speed of sound (SOS), (2) variation in the attenuation coefficient or (3) change in backscattered energy from tissue inhomogeneities. The use of echo shifts has received the most attention in the last decade. By tracking scattering volumes and measuring the time shift of received echoes, investigators have been able to predict the temperature from a region of interest both theoretically and experimentally in phantoms, in isolated tissue regions in vitro and preliminary in vivo studies. A limitation of this method for general temperature monitoring is that prior knowledge of both SOS and thermal-expansion coefficients is necessary. Acoustic attenuation is dependent on temperature, but with significant changes occurring only at temperatures above 50°C, which may lead to its use in thermal ablation therapies. Minimal change in attenuation, however, below this temperature range reduces its attractiveness for use in clinical hyperthermia. Models and measurements of the change in backscattered energy suggest that, over the clinical hyperthermia temperature range, changes in backscattered energy are dependent on the properties of individual scatterers or scattering regions. Calibration of the backscattered energy from different tissue regions is an important goal of this approach. All methods must be able to cope with motion of the image features on which temperature estimates are based. A crucial step in identifying a viable ultrasonic approach to temperature estimation is its performance during in vivo tests.